Healthy volunteers test new drug's safety in early-stage trial
Knowledge-focused
Recruiting now
This early-stage study is testing the safety of a drug called midomafetamine in 32 healthy adults aged 18 to 55. Participants receive either a standard or a higher dose and are closely monitored for side effects, heart changes, and how the drug moves through the body. The results…
Phase: PHASE1 • Sponsor: Resilient Pharmaceuticals • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC